Cytotoxic immune response to a xenogeneic bioartificial liver.
Prior studies have suggested the possibility of immune-mediated death of xenogeneic hepatocytes in a bioartificial liver (BAL) during hemoperfusion. This study was designed to elucidate how immunity may cause death of xenogeneic hepatocytes in the BAL. Healthy dogs were treated with a BAL containing hollow fiber membranes with large pores (200 nm) or small pores (400 kDa). The immune response of recipient dogs to BAL therapy was monitored over 3 h of treatment. We observed significantly greater loss of viability of hepatocytes in the 200 nm group compared with the 400 kDa group (p < 0.001). Low viability after treatment with the large pore membrane was associated with positive staining for dog IgG, dog IgM, and dog complement on dead hepatocytes. Significant levels of dog antibody were detected in samples of BAL medium from the 200 nm group. These canine antibodies were cytotoxic to porcine hepatocytes. In contrast, medium from the 400 kDa group contained only trace levels of dog IgG and were noncytotoxic. We conclude that antibody-mediated cytotoxicity contributed to the death of hepatocytes during treatment with a xenogeneic BAL. Immune-mediated death of hepatocytes was reduced by increasing selectivity of the BAL membrane.
Nyberg
Scott L
SL
Division of Solid Organ Transplantation, Transplantation Biology Program, Mayo Clinic, Rochester, MN 55905, USA. nyberg.scott@mayo.edu
Amiot
Bruce
B
Hardin
Joseph
J
Baskin-Bey
Edwina
E
Platt
Jeffrey L
JL
D000818:Animals; D000910:Antibodies, Heterophile / Q000276:immunology; D016923:Cell Death / Q000276:immunology; D002470:Cell Survival / Q000276:immunology; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic / Q000276:immunology*; D004195:Disease Models, Animal; D004285:Dogs; D006084:Graft Rejection / Q000276:immunology* / Q000503:physiopathology; D006085:Graft Survival / Q000276:immunology; D022781:Hepatocytes / Q000276:immunology / Q000637:transplantation*; D007074:Immunoglobulin G / Q000276:immunology; D019164:Liver, Artificial / Q000009:adverse effects*; D008297:Male; D008567:Membranes, Artificial; D034421:Sus scrofa; D014183:Transplantation, Heterologous / Q000009:adverse effects* / Q000276:immunology / Q000379:methods
D000910:Antibodies, Heterophile; D007074:Immunoglobulin G; D008567:Membranes, Artificial